We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in the coming years.
AstraZeneca has received European Union approval for Imfinzi in combination with FLOT chemotherapy for early-stage and ...
Zacks Investment Research on MSN
Will Anktiva continue to drive ImmunityBio's top-line growth in 2026?
ImmunityBio IBRX had an encouraging year in 2025. Last month, the company reported its fourth-quarter and full-year 2025 ...
Lead program VMT-a-NET in neuroendocrine tumors continues to demonstrate a favorable tolerability profile with durable disease control and deepening of tumor response with longer follow-up, as reporte ...
One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others ...
A 1951 CIA report on parasites and tumors spread online in March 2026 — but it was declassified years ago and does not reveal ...
This might be a long shot, but I was diagnosed with triple negative breast cancer, had a lumpectomy with clear margins and ...
Weight-loss injections like Ozempic may help cancer patients with brain tumours live longer. But experts urge caution before ...
Ethylene oxide rarely makes headlines, yet it quietly sterilizes about half of all medical devices used in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results